These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24094945)

  • 1. Management of sickle cell disease from childhood through adulthood.
    Kanter J; Kruse-Jarres R
    Blood Rev; 2013 Nov; 27(6):279-87. PubMed ID: 24094945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights in the management of sickle cell disease in childhood.
    Iughetti L; Bigi E; Venturelli D
    World J Clin Pediatr; 2016 Feb; 5(1):25-34. PubMed ID: 26862499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents with sickle cell disease in a rural community: are they ready to transition to adulthood?
    Mennito S; Hletko P; Ebeling M; Amann LA; Roberts J
    South Med J; 2014 Sep; 107(9):578-82. PubMed ID: 25188623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem-cell transplantation in children and adults with sickle cell disease: an update.
    Khoury R; Abboud MR
    Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
    Eggleston B; Patience M; Edwards S; Adamkiewicz T; Buchanan GR; Davies SC; Dickerhoff R; Donfield S; Feig SA; Giller RH; Haight A; Horan J; Hsu LL; Kamani N; Lane P; Levine JE; Margolis D; Moore TB; Ohene-Frempong K; Redding-Lallinger R; Roberts IA; Rogers ZR; Sanders JE; Scott JP; Sleight B; Thompson AA; Sullivan KM; Walters MC;
    Br J Haematol; 2007 Feb; 136(4):673-6. PubMed ID: 17223910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.
    Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS
    Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemoglobin F modulation in childhood sickle cell disease.
    Trompeter S; Roberts I
    Br J Haematol; 2009 Feb; 144(3):308-16. PubMed ID: 19036119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.
    Lobo CL; Pinto JF; Nascimento EM; Moura PG; Cardoso GP; Hankins JS
    Br J Haematol; 2013 Jun; 161(6):852-60. PubMed ID: 23590693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From cradle to commencement: transitioning pediatric sickle cell disease patients to adult providers.
    Doulton DM
    J Pediatr Oncol Nurs; 2010; 27(2):119-23. PubMed ID: 19897836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from paediatric to adult care for patients with sickle cell disease.
    de Montalembert M; Guitton C;
    Br J Haematol; 2014 Mar; 164(5):630-5. PubMed ID: 24345037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.
    Matthes-Martin S; Lawitschka A; Fritsch G; Lion T; Grimm B; Breuer S; Boztug H; Karlhuber S; Holter W; Peters C; Minkov M
    Eur J Haematol; 2013 Apr; 90(4):308-12. PubMed ID: 23369103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
    Pack-Mabien A; Haynes J
    J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition and sickle cell disease.
    DeBaun MR; Telfair J
    Pediatrics; 2012 Nov; 130(5):926-35. PubMed ID: 23027174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
    Chakrabarti S; Bareford D
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of health care for children and adults with sickle cell disease.
    Kauf TL; Coates TD; Huazhi L; Mody-Patel N; Hartzema AG
    Am J Hematol; 2009 Jun; 84(6):323-7. PubMed ID: 19358302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in sickle cell anaemia.
    Vermylen C; Cornu G
    Blood Rev; 1993 Mar; 7(1):1-3. PubMed ID: 8467226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.